Characterization of anti-CCL28 as a novel therapy to overcome sorafenib resistance in HCC


Grant Data
Project Title
Characterization of anti-CCL28 as a novel therapy to overcome sorafenib resistance in HCC
Principal Investigator
Professor Ng, Irene Oi Lin   (Principal investigator)
Duration
24
Start Date
2016-05-01
Completion Date
2018-04-30
Amount
1173296
Conference Title
Presentation Title
Keywords
HCC, CCL28, Regulatory T cells, Patient-derived tumor, Sorafenib
Discipline
Others - Medicine, Dentistry and Health
Panel
Medicine
HKU Project Code
03142966
Grant Type
Health and Medical Research Fund - Full Grant
Funding Year
2015/2016
Status
On-going
Objectives
Please refer to hard copy